Core Viewpoint - The Beijing Municipal Medical Insurance Bureau and the Beijing Financial Supervision Bureau have jointly released measures to support the high-quality development of commercial health insurance, focusing on product innovation and data utilization [1][2]. Group 1: Data Utilization and Innovation - The measures propose to advance the development and utilization of medical insurance data, establishing a data-sharing mechanism for medical expenses, health check-ups, and imaging tests, while ensuring data security and compliance [1]. - Medical institutions and pharmaceutical companies are encouraged to provide information on innovative drugs and clinical trial data for commercial insurance companies to aid in product pricing and risk control [1]. Group 2: Support for Product Innovation - The measures support the innovation of commercial insurance products, including disease prediction and intervention insurance, specific disease insurance for cardiovascular diseases and rare diseases, as well as insurance for innovative drugs and clinical liability [2]. - There is encouragement for the development of group health insurance products, commercial nursing insurance, and income loss insurance due to disability, along with support for eligible companies to engage in dividend-type long-term health insurance [2]. - The measures also promote the development of medical insurance products tailored for foreign personnel in China, streamlining the insurance and claims processes while enhancing health management services [2]. Group 3: Development of Inclusive Health Insurance - The measures aim to enhance the development of inclusive health insurance in Beijing by optimizing product protection levels and service rights, dynamically adjusting special drug lists, and strengthening support for innovative drugs and devices [2]. - There is an exploration of improving product sales mechanisms to better leverage the supplementary protection function of inclusive commercial health insurance [2].

时序轮转，华章日新。站在"十五五"开局的新起点，一幅扎根京华、服务首都的金融画卷正徐徐展开。作为华夏银行 在首都的核心分支机构，华夏银行北京分行始终将自身发展融入国家战略和首都发展大局，在服务实体经济、赋能科 技创新、守护民生福祉的实践中担当作为，用实际行动践行首都金融机构的责任。从战略布局到一线实践，从重点项 目到民生服务，华夏银行北京分行秉持"服务首都、深耕本地"的宗旨奋力前行。2025年以来，分行聚焦北京地区，积 极调度金融资源，为首都经济社会发展提供大量金融支持，用专业的金融服务为首都现代化建设贡献坚实力量。 锚定国家大局 擘画协同发展新图景 金融是现代经济的核心，更是服务国家战略的重要支撑。华夏银行北京分行始终将自身发展坐标锚定在国家战略与首 都蓝图上，深刻把握京津冀协同发展的时代机遇，以精准高效的综合金融服务，为非首都功能疏解、现代化首都都市 圈建设和产业协同发展注入金融活水。 立足北京，深耕主场优势。 2025年以来，华夏银行北京分行主动对接北京"3个100"等市区两级重点项目，倾斜资源， 加快审批，精准投放，为重点项目建设提供综合金融服务。分行持续深化政银合作，协助举办"第十一届北京国际老 龄 ...

项目组还提到，特药费用保障今年实现升级，健康人群赔付比例提升至65%，既往症人群赔付比例提升至35%，保险金额 提升至150万元，药品清单增至159种，病种覆盖扩展至87种，为患有重大疾病的参保人提供有力的用药保障支持。自2021年推 出以来，"北京普惠健康保"始终坚守普惠和便民利民的原则，赢得了市民的广泛关注。截至2025年12月份，"北京普惠健康 保"累计受理理赔案件超48万件，最高单笔赔付金额超过76万元，受益人群中年龄最大的104岁，最小的不足1个月。 （编辑 张伟） 本报讯 （记者苏向杲）1月31日，记者从"北京普惠健康保"项目组获悉，作为北京市唯一由政府指导监督的普惠型商业补 充医疗保险产品，2026年度"北京普惠健康保"参保通道将于今晚24时正式关闭。 项目组表示，2026年度"北京普惠健康保"聚焦参保人核心医疗需求。在医保内自付费用保障方面，健康人群免赔额降至 15000元，特定既往症人群免赔额为当年北京市基本医疗大病保险起付标准金额（30404元）；健康人群在15000元—30404元费 用区间新增25%的报销比例，30404元以上费用仍保持80%的报销比例，特定既往症人群报销比例为40%， ...

Group 1 - The company, Yidu Tech (02158), announced a share buyback on January 28, repurchasing 121,800 shares at approximately HKD 6 per share, totaling around HKD 730,000. This marks the fourth consecutive trading day of buybacks, with a total of approximately 830,000 shares repurchased and nearly HKD 5 million spent, signaling confidence to the market [1] - The company has achieved significant progress in business expansion and product implementation, with the number of participants in the 2026 "Beijing Universal Health Insurance" exceeding 4.5 million. As the main operating platform for this project for five consecutive years, Yidu Tech demonstrates its operational strength and market recognition [1] - Yidu Tech has made breakthroughs in the application of AI in primary healthcare, with the "General Medicine Diagnosis AI Assistant" developed in collaboration with Chongqing Medical University First Affiliated Hospital being implemented in over 20 grassroots medical institutions in Chongqing since its trial run in May 2025, serving more than 1,000 healthcare professionals [1]

Core Viewpoint - The company, Yidu Tech (02158), is actively engaging in share buybacks to instill market confidence while simultaneously achieving significant progress in business expansion and product implementation [1] Group 1: Share Buyback Activity - On January 28, Yidu Tech announced a share buyback of approximately 121,800 shares at around HKD 6 per share, costing about HKD 730,000 [1] - The company has conducted buybacks for four consecutive trading days, totaling approximately 830,000 shares and nearly HKD 5 million in expenditure [1] Group 2: Business Expansion - The number of participants in the 2026 "Beijing Universal Health Insurance" program, which Yidu Tech operates, has surpassed 4.5 million [1] - Yidu Tech has been the main operating platform for this project for five consecutive years, demonstrating its operational strength and market recognition [1] Group 3: Technological Advancements - Yidu Tech has made breakthroughs in the application of AI in healthcare, specifically with the "General Medicine Diagnosis AI Assistant" developed in collaboration with Chongqing Medical University [1] - Since its trial run in May 2025, the AI assistant has been implemented in over 20 grassroots medical institutions in Chongqing, serving more than 1,000 healthcare professionals [1]

Core Viewpoint - The company, Yidu Tech (02158), has been actively repurchasing its shares, demonstrating confidence in its intrinsic value and long-term development [1] Group 1: Share Buyback - On January 28, Yidu Tech announced a share buyback of 204,000 shares at approximately HKD 6 per share, costing around HKD 1.23 million [1] - The company has conducted share buybacks for three consecutive trading days, totaling approximately 709,000 shares repurchased and over HKD 4.2 million spent [1] Group 2: Business Progress - The number of insured individuals under the 2026 Beijing Universal Health Insurance program has surpassed 4.5 million, showcasing the company's operational strength and market recognition [1] - Yidu Tech has been the main operating platform for this project for five consecutive years, contributing to the multi-tiered medical security system in the capital [1] Group 3: International Collaboration and Recognition - The founder and chairman of Yidu Tech, Gong Rujing, attended the 2026 Winter Davos Forum, where a collaboration with Novartis Foundation and the Brunei Ministry of Health was announced for a cardiovascular disease prevention project called CARDIO4Cities [1] - Yidu Tech ranked first in the 2025 Medical Big Data Company Rankings for the seventh consecutive year, reflecting its strong technical foundation, mature product system, and extensive industry experience [1]

智通财经APP获悉，1月28日，医渡科技(02158)再度发布股份回购公告，宣布当日以每股约6港元的价格 回购20.4万股，耗资约123万港元。至此，公司已连续三个交易日密集实施回购操作，合计回购约70.9万 股，累计耗资超420万港元，持续以真金白银释放对公司内在价值的认可及长远发展的坚定信心。 除资本端积极动作外，公司主营业务亦传来进展。公司主运营的2026年度北京普惠健康保参保人数已突 破450万，作为连续五年担任该项目主运营平台的企业，医渡科技凭借专业的运营服务与技术赋能，持 续助力首都多层次医疗保障体系建设，进一步彰显了其业务实力与市场认可度。 此前消息显示，医渡科技创始人、董事长宫如璟近期受邀出席2026冬季达沃斯论坛，期间诺华基金会、 文莱卫生部与公司旗下EVYD公司三方合作消息宣布，将联合实施数智驱动的心血管疾病防控项目 CARDIO4Cities，进一步拓展国际合作版图。与此同时，行业权威榜单《2025医疗大数据企业排行榜》 正式揭晓，医渡科技凭借深厚的技术积淀、成熟的产品体系与丰富的行业落地经验，连续第七年斩获榜 首，持续领跑医疗大数据赛道。 ...

项目组表示，2026年度"北京普惠健康保"参保截止时间为2026年1月31日，保障期限为2026年1月1日至 12月31日。 （文章来源：证券日报） 据项目组介绍，该专属服务的领取条件明确，凡持有2023年—2026年度"北京普惠健康保"有效保单，且 截至2025年12月31日24时未达赔付标准（以出险日期为准）的被保险人，均可从六项服务中任选一项免 费体验，全年仅限领取一次，不可重复申领。 项目组提示，2025年12月31日前已预约或已申请但未到店核销权益的参保人，可在2025年12月31日后的 90天内完成使用，该权益一经预约或申请，不支持变更或取消。 本报讯 （记者苏向杲）1月27日，记者从"北京普惠健康保"项目组获悉，截至目前，2026年度"北京普 惠健康保"参保人数突破445万。该保险是北京市唯一一款由政府指导监督的普惠型商业补充医疗保险， 共保体包括六家成员单位。 项目组表示，2026年度"北京普惠健康保"每人每年保费195元，参保不限年龄、不限健康状况，参保通 道将于4天后关闭。近日，为回馈连续参保人，2026年度"北京普惠健康保"推出的六选一专属服务已经 开放领取，符合条件的参保人可关注"北京 ...

2026年度"北京普惠健康保"每人每年保费195元，累计保额350万元，保障范围覆盖医保内自付费用、医 保外住院自费费用及高额海内外药品费用。参保不限年龄、不限健康状况，既往症可保可赔。除本市基 本医保参保人员外，市医保局等相关政府部门管理的特定人群、中央公费医疗参保人，以及拥有本市户 籍或居住证且已参加异地基本医保的新市民均可投保。 来源：北京日报客户端 1月27日，2026年度"北京普惠健康保"参保人数突破445万人。目前距离参保通道关闭仅剩4天，公众如 有需要请及时参保。 此前，2026年度"北京普惠健康保"的参保截止时间已从原定的2025年12月31日延长至2026年1月31日。 公众可在"北京普惠健康保"微信公众号、支付宝或"京通"小程序线上投保；也可通过中国人民保险、中 国人寿、泰康、太平洋保险、中国平安、北京人寿6家保险公司投保；或中国工商银行、中国农业银 行、中国银行、中国建设银行、交通银行、北京银行、北京农商银行等银行的在京线下营业网点投保。 保障期限为2026年1月1日至12月31日。 "北京普惠健康保"专属健康服务也已开放线上领取。符合条件的参保人可免费从牙科检查洁牙、中医按 摩调理、健 ...

阴赪宏委员接受媒体记者采访。 本报记者 甘南摄 沈腾委员接受媒体采访。 实习记者 常一鸣摄 本报记者 陈雪柠 徐慧瑶 杨天悦 市政协十四届四次会议今天开幕。昨天下午，700余名市政协委员陆续报到。大家意气风发、精神饱满，报到过程高效有序。 昨天下午，参加市政协十四届四次会议的委员陆续报到。报到现场，委员们在工作人员的引导下签到、领取相关证件和会议材料。 实习 记者 常一鸣摄 完善公共空间艺术规划与实施 "北京公共空间艺术是城市设计的重要专项内容，应成为提升人居环境品质的工作抓手。"来自致公党界别的市政协委员、北京市城市规 划设计研究院弘都院首席总规划师许槟建议，"十五五"期间，北京锚定国际一流和谐宜居之都建设目标，应进一步落实北京城市总体规 划关于"优化城市公共空间，提升城市魅力与活力"的一系列要求，提高城市综合实力，提升大国首都形象。 许槟介绍，目前全市公共艺术品登记在册约3700件，以城市雕塑、壁画为主，装置、新媒体等形式较少。"将公共空间艺术纳入城市发展 战略已成国际社会共识，而我们现有相关规划是1993年颁布的《北京城市雕塑建设规划纲要》。"许槟建议，完善规划引领，启动公共空 间艺术的专项规划研究，结 ...